Up­start Ex­pan­sion bags a $55M launch round to join the hunt for RNA-tar­get­ing small mol­e­cules

Ar­rakis isn’t the on­ly biotech start­up look­ing to de­vel­op RNA-tar­get­ed small mol­e­cule drugs. Now they have a ri­val in Ex­pan­sion Ther­a­peu­tics, a San Diego-based biotech …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER